Actively Recruiting

Phase 2
Age: 18Years +
All Genders
NCT06377696

Remote Cognitive Assessment and Wearable Device While Assessing the Impact of Metformin in Patients With History of Cranial Radiation Therapy

Led by Mayo Clinic · Updated on 2025-09-02

100

Participants Needed

1

Research Sites

152 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This phase III trial evaluates whether patient care can be done remotely for patients having cranial (skull) radiation or who have previously had cranial radiation. In addition, this trial compares study outcomes between patients who get metformin and those who do not. Cranial radiation, an essential component of brain tumor treatment, can result in significant negative effects on cognitive (the ability to clearly think, learn, and remember) function. Wearable devices have been used in the field of neurology for seizure detection and assessment of patients with movement disorders. Wearable device technology has also been implemented for remote monitoring of cancer patients and for cancer clinical trials. Metformin is the active ingredient in a drug used to treat type 2 diabetes mellitus (a condition in which the body cannot control the level of sugar in the blood). It is also being studied in the treatment of cancer. Use of metformin may reduce risk of cognitive decline following radiation therapy within the skull (intracranial). These effects may be further strengthen by addition of device-based physical activity promotion. Mayo Test Drive is a web-based platform for remote self-administered cognitive assessment. Using Mayo Test Drive may help determine whether patient care can be done remotely, while simultaneously evaluating benefits of health promotion through use of a wearable watch device and metformin in preventing radiation-related cognitive decline.

CONDITIONS

Official Title

Remote Cognitive Assessment and Wearable Device While Assessing the Impact of Metformin in Patients With History of Cranial Radiation Therapy

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Diagnosis of brain tumor requiring cranial radiation treatment; enrollment possible during or up to 5 years after cranial radiation for primary or metastatic intracranial tumor
  • Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2
  • Karnofsky performance status (KPS) of 70 or higher
  • Expected survival of 6 months or more as determined by treatment team
  • Willingness and ability to follow the study protocol, including treatment and scheduled visits
  • Liver enzyme levels (ALT and AST) at or below 3 times the upper limit of normal, or 5 times for those with baseline liver disease, measured within 30 days prior to registration
  • Negative pregnancy test within 8 days prior to registration for persons who can become pregnant
  • Ability to complete cognitive assessments and questionnaires independently or with assistance
Not Eligible

You will not qualify if you...

  • Uncontrolled illness or other condition that limits safety or compliance with the study
  • Pregnant or nursing
  • Prisoner or lacking capacity to understand the study
  • Unable to swallow tablets or at risk for poor absorption of oral medication
  • Currently taking metformin and unable to safely stop if assigned to control group
  • Known allergy or hypersensitivity to metformin
  • Using resveratrol, CoQ10, coconut oil or other medium chain triglyceride supplements, or curcumin and unwilling to stop before and during the study
  • Unable to read and speak English as required for the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Mayo Clinic in Rochester

Rochester, Minnesota, United States, 55905

Actively Recruiting

Loading map...

Research Team

C

Clinical Trials Referral Office

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here